SHOCKWAVE MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 328.9 USD | +0.11% |
|
+0.42% | +72.58% |
| Apr. 11 | Health Care Slips on Risk Bias -- Health Care Roundup | DJ |
| Apr. 09 | CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368 | MT |
Financials (USD)
| Sales 2024 * | 921M | Sales 2025 * | 1.13B | Capitalization | 12.34B |
|---|---|---|---|---|---|
| Net income 2024 * | 187M | Net income 2025 * | 243M | EV / Sales 2024 * | 12.8 x |
| Net cash position 2024 * | 509M | Net cash position 2025 * | 817M | EV / Sales 2025 * | 10.2 x |
| P/E ratio 2024 * |
68
x | P/E ratio 2025 * |
53.5
x | Employees | 1,468 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
More Fundamentals
* Assessed data
More news
Latest transcript on Shockwave Medical, Inc.
More recommendations
More press releases
| 1 day | +0.11% | ||
| 1 week | +0.42% | ||
| Current month | +0.99% | ||
| 1 month | +17.06% | ||
| 3 months | +46.49% | ||
| 6 months | +53.30% | ||
| Current year | +72.58% |
1 week
327.39
329.80
1 month
287.59331.58
Current year
186.33331.58
1 year
157.00331.58
3 years
113.36331.58
5 years
22.01331.58
10 years
22.01331.58
| Managers | Title | Age | Since |
|---|---|---|---|
Douglas Godshall
CEO | Chief Executive Officer | 59 | 17-04-30 |
Isaac Zacharias
PSD | President | 49 | 18-10-31 |
Renee Gaeta
DFI | Director of Finance/CFO | 42 | Feb. 04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 20-07-15 | |
Kevin Ballinger
BRD | Director/Board Member | 51 | 23-05-15 |
Frederic Moll
BRD | Director/Board Member | 72 | 11-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.49% | 2 M€ | -1.17% | - | |
| 1.27% | 16 M€ | -7.62% | ||
| 0.27% | 509 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 328.9 | +0.10% | 1,355,072 |
| 24-04-23 | 328.5 | -0.02% | 889,386 |
| 24-04-22 | 328.6 | -0.12% | 718,730 |
| 24-04-19 | 329 | +0.45% | 1,302,719 |
| 24-04-18 | 327.5 | +0.01% | 1,155,587 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotes
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
Calendar
2024-05-05
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
328.9
USD
Average target price
294.3
USD
Spread / Average Target
-10.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +72.58% | 12.34B | |
| -18.04% | 7.98B | |
| +4.73% | 5.81B | |
| +6.65% | 5.04B | |
| +20.83% | 4.31B | |
| -20.27% | 4.03B | |
| -41.19% | 2.21B | |
| +0.87% | 1.99B | |
| +4.02% | 1.87B | |
| -41.64% | 1.33B |
- Stock Market
- Equities
- SWAV Stock
